M Visalli

Efflux-Mediated Resistance to Tigecycline (GAR-936) in <i>Pseudomonas aeruginosa</i> PAO1

Charles R. Dean, M Visalli, Steven J. Projan et al. · Antimicrobial Agents and Chemotherapy · 2003 · 281 citations · Full text

Bacteriology, Antibiotic Resistance, Bacterial Pathogens +18

Influence of Transcriptional Activator RamA on Expression of Multidrug Efflux Pump AcrAB and Tigecycline Susceptibility in <i>Klebsiella pneumoniae</i>

Alexey Ruzin, M Visalli, David Keeney et al. · Antimicrobial Agents and Chemotherapy · 2005 · 203 citations · Full text

Klebsiella Pneumoniae, Immunology, Antimicrobial Chemotherapy +19

AcrAB Multidrug Efflux Pump Is Associated with Reduced Levels of Susceptibility to Tigecycline (GAR-936) in <i>Proteus mirabilis</i>

M Visalli, Ellen Murphy, Steven J. Projan et al. · Antimicrobial Agents and Chemotherapy · 2003 · 165 citations · Full text

Bacteriology, Molecular Biology, Reduced Levels +16

Determining incidence of extended spectrum β-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001–2002

S. Bouchillon, Brian Johnson, D. Hoban et al. · International Journal of Antimicrobial Agents · 2004 · 141 citations

Vancomycin-resistant Enterococcus Faecium, Extended Spectrum, Antibiotic Resistance +16

Susceptibilities of Penicillin- and Erythromycin-Susceptible and -Resistant Pneumococci to HMR 3647 (RU 66647), a New Ketolide, Compared with Susceptibilities to 17 Other Agents

Glenn A. Pankuch, M Visalli, Michael R. Jacobs et al. · Antimicrobial Agents and Chemotherapy · 1998 · 140 citations · Full text